期刊
JOURNAL OF MEDICINAL CHEMISTRY
卷 53, 期 5, 页码 2277-2285出版社
AMER CHEMICAL SOC
DOI: 10.1021/jm901855h
关键词
-
资金
- European Union [CNRS MIE-2007]
A beta-carbonic anhydrase (CA, EC 4.2.1.1) from the bacterial pathogen Brucella suis, bsCA 1, has been cloned, purified, and characterized kinetically. bsCA I has appreciable activity as catalyst for the hydration of CO2 to bicarbonate, with it k(cat) of 6.4 x 10(5) s(-1) and k(cat)/K-m of 3.9 x 10(7) M-1.s(-1). A panel of 38 sulfonamides and one sulfamate have been investigated for inhibition of this new beta-CA. All types of activities have been detected, with K(t)s in the range of 17 nM to 5.87 mu M. The best bsCA 1 inhibitors were ethoxzolamide (17 nM), celecoxib (18 nM), dorzolamide (21 nM), valdecoxib, and sulpiride (19 nM). Whether bsCA 1 inhibitors may have application in the Fight against brucellosis, an endemic disease and the major bacterial zoonosis, producing debilitating infection in humans and animals, warrants further studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据